ClinConnect ClinConnect Logo
Search / Trial NCT05377476

Investigation of the Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis

Launched by HACETTEPE UNIVERSITY · May 16, 2022

Trial Information

Current as of June 25, 2025

Completed

Keywords

Multiple Sclerosis Motor Imagery Action Observation Walking Fatigue Muscle Oxygenation

ClinConnect Summary

This clinical trial is exploring the effects of two specific types of training—motor imagery and action observation training—on people with Multiple Sclerosis (MS). The goal is to see if these training methods, when added to standard rehabilitation, can improve important aspects like walking ability, fatigue levels, trunk control, and muscle oxygenation in individuals living with MS.

To join the study, participants need to be between 18 and 65 years old and have a confirmed diagnosis of MS. They should have a moderate disability level (measured by a standard scale) and must not have experienced an MS attack in the last three months. The study is looking for both men and women, and it is currently recruiting participants. Those who qualify can expect to engage in specific training sessions while receiving regular rehabilitation support, helping researchers understand how these new methods might enhance their recovery and daily functioning.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 18-65
  • A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
  • Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
  • Not having an attack in the last 3 months
  • A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)
  • Exclusion Criteria:
  • cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
  • Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
  • Having severe vision and hearing problems

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Melike Sumeyye Ozen, M.Sc.

Principal Investigator

Bandırma Onyedi Eylül University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials